{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T19:49:09Z","timestamp":1784317749379,"version":"3.55.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T00:00:00Z","timestamp":1747440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T00:00:00Z","timestamp":1747440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 112-2221-E-A49-088-MY3"],"award-info":[{"award-number":["NSTC 112-2221-E-A49-088-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum Genomics"],"DOI":"10.1186\/s40246-025-00763-4","type":"journal-article","created":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T16:51:12Z","timestamp":1747500672000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Exploring potential methylation markers for ovarian cancer from cervical scraping samples"],"prefix":"10.1186","volume":"19","author":[{"given":"Ju-Yin","family":"Lien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu Ann","family":"Hii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Hsuan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Chang","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Cheng","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,17]]},"reference":[{"key":"763_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"763_CR2","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1111\/j.1471-0528.2005.00572.x","volume":"112","author":"CR Bankhead","year":"2005","unstructured":"Bankhead CR, Kehoe ST, Austoker J. Symptoms associated with diagnosis of ovarian cancer: a systematic review. BJOG. 2005;112:857\u201365.","journal-title":"BJOG"},{"key":"763_CR3","doi-asserted-by":"crossref","unstructured":"Donovan KA, Donovan HS, Cella D, Gaines ME, Penson RT, Plaxe SC, von Gruenigen VE, Bruner DW, Reeve BB, Wenzel L. Recommended patient-reported core set of symptoms and quality-of-life domains to measure in ovarian cancer treatment trials. J Natl Cancer Inst 2014, 106.","DOI":"10.1093\/jnci\/dju128"},{"key":"763_CR4","doi-asserted-by":"publisher","first-page":"100204","DOI":"10.1016\/j.clinsp.2023.100204","volume":"78","author":"B Gutic","year":"2023","unstructured":"Gutic B, Bozanovic T, Mandic A, Dugalic S, Todorovic J, Dugalic MG, Sengul D, Detanac DA, Sengul I, Detanac D, et al. Preliminary outcomes of five-year survival for ovarian malignancies in profiled Serbian oncology centre. Clin (Sao Paulo). 2023;78:100204.","journal-title":"Clin (Sao Paulo)"},{"key":"763_CR5","unstructured":"National Cancer Institute. Surveillance, Epidemiology, and End Results Program. Cancer stat facts: ovarian cancer. [https:\/\/www.seer.cancer.gov\/statfacts\/html\/ovary.html]"},{"key":"763_CR6","doi-asserted-by":"crossref","unstructured":"Kobel M, Kang EY. The evolution of ovarian carcinoma subclassification. Cancers (Basel) 2022, 14.","DOI":"10.3390\/cancers14020416"},{"key":"763_CR7","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.soncn.2019.02.001","volume":"35","author":"C Stewart","year":"2019","unstructured":"Stewart C, Ralyea C, Lockwood S. Ovarian cancer: an integrated review. Semin Oncol Nurs. 2019;35:151\u20136.","journal-title":"Semin Oncol Nurs"},{"key":"763_CR8","doi-asserted-by":"publisher","first-page":"188503","DOI":"10.1016\/j.bbcan.2021.188503","volume":"1875","author":"M Zhang","year":"2021","unstructured":"Zhang M, Cheng S, Jin Y, Zhao Y, Wang Y. Roles of CA125 in diagnosis, prediction, and oncogenesis of ovarian cancer. Biochim Biophys Acta Rev Cancer. 2021;1875:188503.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"763_CR9","doi-asserted-by":"publisher","first-page":"100152","DOI":"10.1016\/j.ctarc.2019.100152","volume":"21","author":"I Hellstrom","year":"2019","unstructured":"Hellstrom I, Yip YY, Darvas M, Swisher E, Hellstrom KE. Ovarian carcinomas express HE4 epitopes independently of each other. Cancer Treat Res Commun. 2019;21:100152.","journal-title":"Cancer Treat Res Commun"},{"key":"763_CR10","doi-asserted-by":"crossref","unstructured":"Zhang R, Siu MKY, Ngan HYS, Chan KKL. Molecular biomarkers for the early detection of ovarian Cancer. Int J Mol Sci 2022, 23.","DOI":"10.3390\/ijms231912041"},{"key":"763_CR11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11912-019-0816-0","volume":"21","author":"DR Nebgen","year":"2019","unstructured":"Nebgen DR, Lu KH, Bast RC Jr. Novel approaches to ovarian Cancer screening. Curr Oncol Rep. 2019;21:75.","journal-title":"Curr Oncol Rep"},{"key":"763_CR12","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1586\/erm.09.39","volume":"9","author":"J Li","year":"2009","unstructured":"Li J, Dowdy S, Tipton T, Podratz K, Lu WG, Xie X, Jiang SW. HE4 as a biomarker for ovarian and endometrial cancer management. Expert Rev Mol Diagn. 2009;9:555\u201366.","journal-title":"Expert Rev Mol Diagn"},{"key":"763_CR13","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.ygyno.2012.09.034","volume":"128","author":"KK Chan","year":"2013","unstructured":"Chan KK, Chen CA, Nam JH, Ochiai K, Wilailak S, Choon AT, Sabaratnam S, Hebbar S, Sickan J, Schodin BA, Sumpaico WW. The use of HE4 in the prediction of ovarian cancer in Asian women with a pelvic mass. Gynecol Oncol. 2013;128:239\u201344.","journal-title":"Gynecol Oncol"},{"key":"763_CR14","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1080\/15384047.2020.1843323","volume":"21","author":"J Kim","year":"2020","unstructured":"Kim J, Beidler P, Wang H, Li C, Quassab A, Coles C, Drescher C, Carter D, Lieber A. Desmoglein-2 as a prognostic and biomarker in ovarian cancer. Cancer Biol Ther. 2020;21:1154\u201362.","journal-title":"Cancer Biol Ther"},{"key":"763_CR15","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/S0140-6736(15)01224-6","volume":"387","author":"IJ Jacobs","year":"2016","unstructured":"Jacobs IJ, Menon U, Ryan A, Gentry-Maharaj A, Burnell M, Kalsi JK, Amso NN, Apostolidou S, Benjamin E, Cruickshank D, et al. Ovarian cancer screening and mortality in the UK collaborative trial of ovarian Cancer screening (UKCTOCS): a randomised controlled trial. Lancet. 2016;387:945\u201356.","journal-title":"Lancet"},{"key":"763_CR16","doi-asserted-by":"publisher","first-page":"167ra164","DOI":"10.1126\/scitranslmed.3004952","volume":"5","author":"I Kinde","year":"2013","unstructured":"Kinde I, Bettegowda C, Wang Y, Wu J, Agrawal N, Shih Ie M, Kurman R, Dao F, Levine DA, Giuntoli R, et al. Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers. Sci Transl Med. 2013;5:167ra164.","journal-title":"Sci Transl Med"},{"key":"763_CR17","doi-asserted-by":"crossref","unstructured":"Wang Y, Li L, Douville C, Cohen JD, Yen TT, Kinde I, Sundfelt K, Kjaer SK, Hruban RH, Shih IM et al. Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers. Sci Transl Med 2018, 10.","DOI":"10.1126\/scitranslmed.aap8793"},{"key":"763_CR18","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13048-020-00632-9","volume":"13","author":"G Gong","year":"2020","unstructured":"Gong G, Lin T, Yuan Y. Integrated analysis of gene expression and DNA methylation profiles in ovarian cancer. J Ovarian Res. 2020;13:30.","journal-title":"J Ovarian Res"},{"key":"763_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1556\/650.2018.30927","volume":"159","author":"KA Szigeti","year":"2018","unstructured":"Szigeti KA, Galamb O, Kalmar A, Bartak BK, Nagy ZB, Markus E, Igaz P, Tulassay Z, Molnar B. [Role and alterations of DNA methylation during the aging and cancer]. Orv Hetil. 2018;159:3\u201315.","journal-title":"Orv Hetil"},{"key":"763_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/npp.2012.112","volume":"38","author":"LD Moore","year":"2013","unstructured":"Moore LD, Le T, Fan G. DNA methylation and its basic function. Neuropsychopharmacology. 2013;38:23\u201338.","journal-title":"Neuropsychopharmacology"},{"key":"763_CR21","doi-asserted-by":"publisher","first-page":"11891","DOI":"10.1073\/pnas.95.20.11891","volume":"95","author":"SA Belinsky","year":"1998","unstructured":"Belinsky SA, Nikula KJ, Palmisano WA, Michels R, Saccomanno G, Gabrielson E, Baylin SB, Herman JG. Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. Proc Natl Acad Sci U S A. 1998;95:11891\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"763_CR22","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1056\/NEJMoa0706550","volume":"358","author":"MV Brock","year":"2008","unstructured":"Brock MV, Hooker CM, Ota-Machida E, Han Y, Guo M, Ames S, Glockner S, Piantadosi S, Gabrielson E, Pridham G, et al. DNA methylation markers and early recurrence in stage I lung cancer. N Engl J Med. 2008;358:1118\u201328.","journal-title":"N Engl J Med"},{"key":"763_CR23","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1373\/clinchem.2007.095992","volume":"54","author":"C Lofton-Day","year":"2008","unstructured":"Lofton-Day C, Model F, Devos T, Tetzner R, Distler J, Schuster M, Song X, Lesche R, Liebenberg V, Ebert M, et al. DNA methylation biomarkers for blood-based colorectal cancer screening. Clin Chem. 2008;54:414\u201323.","journal-title":"Clin Chem"},{"key":"763_CR24","doi-asserted-by":"publisher","first-page":"188722","DOI":"10.1016\/j.bbcan.2022.188722","volume":"1877","author":"D Muller","year":"2022","unstructured":"Muller D, Gyorffy B. DNA methylation-based diagnostic, prognostic, and predictive biomarkers in colorectal cancer. Biochim Biophys Acta Rev Cancer. 2022;1877:188722.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"763_CR25","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1056\/NEJMoa1311194","volume":"370","author":"TF Imperiale","year":"2014","unstructured":"Imperiale TF, Ransohoff DF, Itzkowitz SH, Levin TR, Lavin P, Lidgard GP, Ahlquist DA, Berger BM. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med. 2014;370:1287\u201397.","journal-title":"N Engl J Med"},{"key":"763_CR26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1476-4598-6-45","volume":"6","author":"Q Wu","year":"2007","unstructured":"Wu Q, Lothe RA, Ahlquist T, Silins I, Trope CG, Micci F, Nesland JM, Suo Z, Lind GE. DNA methylation profiling of ovarian carcinomas and their in vitro models identifies HOXA9, HOXB5, SCGB3A1, and CRABP1 as novel targets. Mol Cancer. 2007;6:45.","journal-title":"Mol Cancer"},{"key":"763_CR27","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s12094-012-0894-z","volume":"15","author":"M Chmelarova","year":"2013","unstructured":"Chmelarova M, Krepinska E, Spacek J, Laco J, Beranek M, Palicka V. Methylation in the p53 promoter in epithelial ovarian cancer. Clin Transl Oncol. 2013;15:160\u20133.","journal-title":"Clin Transl Oncol"},{"key":"763_CR28","doi-asserted-by":"crossref","unstructured":"Fu M, Deng F, Chen J, Fu L, Lei J, Xu T, Chen Y, Zhou J, Gao Q, Ding H. Current data and future perspectives on DNA methylation in ovarian cancer (Review). Int J Oncol 2024, 64.","DOI":"10.3892\/ijo.2024.5650"},{"key":"763_CR29","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.3802\/jgo.2021.32.e23","volume":"32","author":"Y Jung","year":"2021","unstructured":"Jung Y, Hur S, Liu J, Lee S, Kang BS, Kim M, Choi YJ. Peripheral blood BRCA1 methylation profiling to predict Familial ovarian cancer. J Gynecol Oncol. 2021;32:e23.","journal-title":"J Gynecol Oncol"},{"key":"763_CR30","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ygyno.2010.09.019","volume":"120","author":"TE Liggett","year":"2011","unstructured":"Liggett TE, Melnikov A, Yi Q, Replogle C, Hu W, Rotmensch J, Kamat A, Sood AK, Levenson V. Distinctive DNA methylation patterns of cell-free plasma DNA in women with malignant ovarian tumors. Gynecol Oncol. 2011;120:113\u201320.","journal-title":"Gynecol Oncol"},{"key":"763_CR31","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1002\/cncr.35130","volume":"130","author":"X Zhao","year":"2024","unstructured":"Zhao X, Yang M, Fan J, Wang M, Wang Y, Qin N, Zhu M, Jiang Y, Gorlova OY, Gorlov IP, et al. Identification of genetically predicted DNA methylation markers associated with non-small cell lung cancer risk among 34,964 cases and 448,579 controls. Cancer. 2024;130:913\u201326.","journal-title":"Cancer"},{"key":"763_CR32","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/s41467-021-26615-y","volume":"13","author":"JE Barrett","year":"2022","unstructured":"Barrett JE, Jones A, Evans I, Reisel D, Herzog C, Chindera K, Kristiansen M, Leavy OC, Manchanda R, Bjorge L, et al. The DNA methylome of cervical cells can predict the presence of ovarian cancer. Nat Commun. 2022;13:448.","journal-title":"Nat Commun"},{"key":"763_CR33","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1093\/bioinformatics\/btu049","volume":"30","author":"MJ Aryee","year":"2014","unstructured":"Aryee MJ, Jaffe AE, Corrada-Bravo H, Ladd-Acosta C, Feinberg AP, Hansen KD, Irizarry RA. Minfi: a flexible and comprehensive bioconductor package for the analysis of infinium DNA methylation microarrays. Bioinformatics. 2014;30:1363\u20139.","journal-title":"Bioinformatics"},{"key":"763_CR34","unstructured":"ChAMP. The Chip Analysis Methylation Pipeline. NBeads filter criteria. [https:\/\/bioconductor.org\/packages\/release\/bioc\/vignettes\/ChAMP\/inst\/doc\/ChAMP.html"},{"key":"763_CR35","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1093\/bioinformatics\/btw691","volume":"33","author":"JP Fortin","year":"2017","unstructured":"Fortin JP, Triche TJ Jr., Hansen KD. Preprocessing, normalization and integration of the illumina humanmethylationepic array with Minfi. Bioinformatics. 2017;33:558\u201360.","journal-title":"Bioinformatics"},{"key":"763_CR36","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/bioinformatics\/bts680","volume":"29","author":"AE Teschendorff","year":"2013","unstructured":"Teschendorff AE, Marabita F, Lechner M, Bartlett T, Tegner J, Gomez-Cabrero D, Beck S. A beta-mixture quantile normalization method for correcting probe design bias in illumina infinium 450 K DNA methylation data. Bioinformatics. 2013;29:189\u201396.","journal-title":"Bioinformatics"},{"key":"763_CR37","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1186\/1471-2105-11-587","volume":"11","author":"P Du","year":"2010","unstructured":"Du P, Zhang X, Huang CC, Jafari N, Kibbe WA, Hou L, Lin SM. Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis. BMC Bioinformatics. 2010;11:587.","journal-title":"BMC Bioinformatics"},{"key":"763_CR38","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.gdata.2016.05.012","volume":"9","author":"DL McCartney","year":"2016","unstructured":"McCartney DL, Walker RM, Morris SW, McIntosh AM, Porteous DJ, Evans KL. Identification of polymorphic and off-target probe binding sites on the illumina infinium methylationepic BeadChip. Genom Data. 2016;9:22\u20134.","journal-title":"Genom Data"},{"key":"763_CR39","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s13059-016-1066-1","volume":"17","author":"R Pidsley","year":"2016","unstructured":"Pidsley R, Zotenko E, Peters TJ, Lawrence MG, Risbridger GP, Molloy P, Van Djik S, Muhlhausler B, Stirzaker C, Clark SJ. Critical evaluation of the illumina methylationepic BeadChip microarray for whole-genome DNA methylation profiling. Genome Biol. 2016;17:208.","journal-title":"Genome Biol"},{"key":"763_CR40","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1093\/bioinformatics\/btv560","volume":"32","author":"B Phipson","year":"2016","unstructured":"Phipson B, Maksimovic J, Oshlack A. MissMethyl: an R package for analyzing data from Illumina\u2019s HumanMethylation450 platform. Bioinformatics. 2016;32:286\u20138.","journal-title":"Bioinformatics"},{"key":"763_CR41","unstructured":"Carlson M. GO.db: A set of annotation maps describing the entire gene ontology. 3.8.2 edition; 2019."},{"key":"763_CR42","doi-asserted-by":"publisher","first-page":"R8","DOI":"10.1186\/gb-2012-13-2-r8","volume":"13","author":"HB Fraser","year":"2012","unstructured":"Fraser HB, Lam LL, Neumann SM, Kobor MS. Population-specificity of human DNA methylation. Genome Biol. 2012;13:R8.","journal-title":"Genome Biol"},{"key":"763_CR43","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1101\/gr.154187.112","volume":"23","author":"H Heyn","year":"2013","unstructured":"Heyn H, Moran S, Hernando-Herraez I, Sayols S, Gomez A, Sandoval J, Monk D, Hata K, Marques-Bonet T, Wang L, Esteller M. DNA methylation contributes to natural human variation. Genome Res. 2013;23:1363\u201372.","journal-title":"Genome Res"},{"key":"763_CR44","doi-asserted-by":"publisher","first-page":"REVIEWS1027","DOI":"10.1186\/gb-2001-2-10-reviews1027","volume":"2","author":"C Crasto","year":"2001","unstructured":"Crasto C, Singer MS, Shepherd GM. The olfactory receptor family album. Genome Biol. 2001;2:REVIEWS1027.","journal-title":"Genome Biol"},{"key":"763_CR45","doi-asserted-by":"publisher","first-page":"650","DOI":"10.3892\/ol.2021.12911","volume":"22","author":"R Kerslake","year":"2021","unstructured":"Kerslake R, Hall M, Vagnarelli P, Jeyaneethi J, Randeva HS, Pados G, Kyrou I, Karteris E. A Pancancer overview of FBN1, Asprosin and its cognate receptor OR4M1 with detailed expression profiling in ovarian cancer. Oncol Lett. 2021;22:650.","journal-title":"Oncol Lett"},{"key":"763_CR46","doi-asserted-by":"publisher","first-page":"72","DOI":"10.5483\/BMBRep.2022.55.2.010","volume":"55","author":"C Chung","year":"2022","unstructured":"Chung C, Cho HJ, Lee C, Koo J. Odorant receptors in cancer. BMB Rep. 2022;55:72\u201380.","journal-title":"BMB Rep"},{"key":"763_CR47","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3389\/fphys.2018.00456","volume":"9","author":"L Weber","year":"2018","unstructured":"Weber L, Schulz WA, Philippou S, Eckardt J, Ubrig B, Hoffmann MJ, Tannapfel A, Kalbe B, Gisselmann G, Hatt H. Characterization of the olfactory receptor OR10H1 in human urinary bladder Cancer. Front Physiol. 2018;9:456.","journal-title":"Front Physiol"},{"key":"763_CR48","first-page":"375","volume":"31","author":"M Nowak","year":"2010","unstructured":"Nowak M, Glowacka E, Szpakowski M, Szyllo K, Malinowski A, Kulig A, Tchorzewski H, Wilczynski J. Proinflammatory and immunosuppressive serum, Ascites and cyst fluid cytokines in patients with early and advanced ovarian cancer and benign ovarian tumors. Neuro Endocrinol Lett. 2010;31:375\u201383.","journal-title":"Neuro Endocrinol Lett"},{"key":"763_CR49","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1158\/1535-7163.MCT-05-0303","volume":"5","author":"PW Szlosarek","year":"2006","unstructured":"Szlosarek PW, Grimshaw MJ, Kulbe H, Wilson JL, Wilbanks GD, Burke F, Balkwill FR. Expression and regulation of tumor necrosis factor alpha in normal and malignant ovarian epithelium. Mol Cancer Ther. 2006;5:382\u201390.","journal-title":"Mol Cancer Ther"},{"key":"763_CR50","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.cyto.2012.01.015","volume":"58","author":"A Maccio","year":"2012","unstructured":"Maccio A, Madeddu C. Inflammation and ovarian cancer. Cytokine. 2012;58:133\u201347.","journal-title":"Cytokine"},{"key":"763_CR51","first-page":"61","volume":"8","author":"AJ Knights","year":"2012","unstructured":"Knights AJ, Funnell AP, Crossley M, Pearson RC. Holding tight: cell junctions and Cancer spread. Trends Cancer Res. 2012;8:61\u20139.","journal-title":"Trends Cancer Res"},{"key":"763_CR52","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s11033-023-08920-5","volume":"51","author":"J Yayan","year":"2024","unstructured":"Yayan J, Franke KJ, Berger M, Windisch W, Rasche K. Adhesion, metastasis, and Inhibition of cancer cells: a comprehensive review. Mol Biol Rep. 2024;51:165.","journal-title":"Mol Biol Rep"},{"key":"763_CR53","doi-asserted-by":"publisher","first-page":"e10862","DOI":"10.1016\/j.heliyon.2022.e10862","volume":"8","author":"MC Neville","year":"2022","unstructured":"Neville MC, Webb PG, Baumgartner HK, Bitler BG. Claudin-4 localization in epithelial ovarian cancer. Heliyon. 2022;8:e10862.","journal-title":"Heliyon"},{"key":"763_CR54","doi-asserted-by":"crossref","unstructured":"Cumin C, Huang YL, Everest-Dass A, Jacob F. Deciphering the importance of glycosphingolipids on cellular and molecular mechanisms associated with Epithelial-to-Mesenchymal transition in Cancer. Biomolecules 2021, 11.","DOI":"10.3390\/biom11010062"},{"key":"763_CR55","doi-asserted-by":"publisher","first-page":"4869","DOI":"10.1182\/blood-2012-06-438598","volume":"120","author":"MS Cho","year":"2012","unstructured":"Cho MS, Bottsford-Miller J, Vasquez HG, Stone R, Zand B, Kroll MH, Sood AK, Afshar-Kharghan V. Platelets increase the proliferation of ovarian cancer cells. Blood. 2012;120:4869\u201372.","journal-title":"Blood"},{"key":"763_CR56","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.7150\/jca.15074","volume":"7","author":"L Fan","year":"2016","unstructured":"Fan L, Yin M, Ke C, Ge T, Zhang G, Zhang W, Zhou X, Lou G, Li K. Use of plasma metabolomics to identify diagnostic biomarkers for early stage epithelial ovarian Cancer. J Cancer. 2016;7:1265\u201372.","journal-title":"J Cancer"},{"key":"763_CR57","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00018-022-04278-2","volume":"79","author":"T Rezen","year":"2022","unstructured":"Rezen T, Rozman D, Kovacs T, Kovacs P, Sipos A, Bai P, Miko E. The role of bile acids in carcinogenesis. Cell Mol Life Sci. 2022;79:243.","journal-title":"Cell Mol Life Sci"},{"key":"763_CR58","first-page":"323","volume":"10","author":"JL Hentze","year":"2019","unstructured":"Hentze JL, Hogdall CK, Hogdall EV. Methylation and ovarian cancer: can DNA methylation be of diagnostic use? Mol Clin Oncol. 2019;10:323\u201330.","journal-title":"Mol Clin Oncol"},{"key":"763_CR59","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1136\/ijgc-2024-005313","volume":"34","author":"C Taliento","year":"2024","unstructured":"Taliento C, Morciano G, Nero C, Froyman W, Vizzielli G, Pavone M, Salvioli S, Tormen M, Fiorica F, Scutiero G, et al. Circulating tumor DNA as a biomarker for predicting progression-free survival and overall survival in patients with epithelial ovarian cancer: a systematic review and meta-analysis. Int J Gynecol Cancer. 2024;34:906\u201318.","journal-title":"Int J Gynecol Cancer"},{"key":"763_CR60","doi-asserted-by":"publisher","first-page":"100038","DOI":"10.1016\/j.modpat.2022.100038","volume":"36","author":"N Shaker","year":"2023","unstructured":"Shaker N, Chen W, Sinclair W, Parwani AV, Li Z. Identifying SOX17 as a sensitive and specific marker for ovarian and endometrial carcinomas. Mod Pathol. 2023;36:100038.","journal-title":"Mod Pathol"},{"key":"763_CR61","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13148-023-01440-w","volume":"15","author":"SK Terp","year":"2023","unstructured":"Terp SK, Stoico MP, Dybkaer K, Pedersen IS. Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review. Clin Epigenetics. 2023;15:24.","journal-title":"Clin Epigenetics"},{"key":"763_CR62","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.ygyno.2021.06.028","volume":"162","author":"B Werner","year":"2021","unstructured":"Werner B, Yuwono N, Duggan J, Liu D, David C, Srirangan S, Provan P, Investigators IN, DeFazio A, Arora V, et al. Cell-free DNA is abundant in Ascites and represents a liquid biopsy of ovarian cancer. Gynecol Oncol. 2021;162:720\u20137.","journal-title":"Gynecol Oncol"}],"container-title":["Human Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-025-00763-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40246-025-00763-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-025-00763-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T18:03:04Z","timestamp":1747504984000},"score":1,"resource":{"primary":{"URL":"https:\/\/humgenomics.biomedcentral.com\/articles\/10.1186\/s40246-025-00763-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,17]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["763"],"URL":"https:\/\/doi.org\/10.1186\/s40246-025-00763-4","relation":{},"ISSN":["1479-7364"],"issn-type":[{"value":"1479-7364","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,17]]},"assertion":[{"value":"7 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Specimens were collected according to institutional policies, and participants with incomplete clinical\/pathological results were excluded. The protocol and informed consent forms were approved by the Taipei Medical University IRB (N201810036). Written informed consent was obtained from all participants prior to their enrollment in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"56"}}